How to reconstitute peptides.
What reconstitution is, why peptides ship as white powder, what happens if you choose the wrong diluent, the step-by-step technique that protects peptide integrity, how degradation actually works (and what signs to look for), and how long a reconstituted vial is realistically useful. This covers technique and the concentration math; it does not recommend doses.
Reviewed June 1, 2026
- Most peptides ship as freeze-dried (lyophilised) white powder because they're up to 100× more stable dry than in solution.
- Diluent choice is not interchangeable. Some peptides require acetic acid to dissolve due to pH-dependent aggregation chemistry.
- Never shake a reconstituted vial. Vigorous shaking denatures peptide chains, creates immune-triggering aggregates, and makes accurate measurement impossible.
- Bacteriostatic water (BAC) with 0.9% benzyl alcohol supports multi-use vials for approximately 28–60 days refrigerated; sterile water is single-use within 24 hours.
Why peptides ship as white powder.
Lyophilisation (freeze-drying) is a two-stage process: the peptide is first frozen, then placed in a vacuum chamber where the temperature is gently raised so ice sublimates directly into vapour, bypassing the liquid phase. What remains is a dry, porous solid called a “cake”: a form of the peptide that can be stable for years at -20°C and months at room temperature, compared to hours or days in solution. This 100× stability improvement explains why pharmaceutical and research peptides use lyophilisation: it dramatically extends shelf life and simplifies shipping.
The white powder appearance comes from the excipients (stabilising additives) used in pharmaceutical lyophilisation. Mannitol, sucrose, or trehalose are common cryoprotectants that prevent ice crystal formation from physically damaging the peptide during freezing. Research-grade peptides from vendors may or may not contain these excipients, affecting both the appearance of the powder and its reconstitution behaviour. A slightly yellow tint to the powder is normal for some sequences; brown, dark, or strongly discoloured powder suggests degradation.
Choosing your diluent.
The diluent is not just water. It's a pH environment, a sterility system, and a stability medium for the dissolved peptide. Choosing the wrong one can cause the peptide to aggregate immediately, destabilise it over time, or create an uncomfortable injection. Four main options exist:
- 01Bacteriostatic water (BAC water). Sterile water containing 0.9% benzyl alcohol. The standard choice for most research peptides. The benzyl alcohol inhibits bacterial and fungal growth, allowing a multi-dose vial to be drawn from repeatedly over 28–60 days when refrigerated. Nearly universal compatibility; does not alter peptide chemistry for most sequences. USP-standard; available without prescription as a pharmaceutical product.
- 02Sterile water for injection (WFI). Pure sterile water with no preservative. Used for single-dose preparations only. Once punctured, contamination risk begins immediately. Industry guidance is to use within 24 hours or discard. Appropriate for cell culture work where benzyl alcohol is cytotoxic, and for peptides that react negatively with benzyl alcohol (rare). Not practical for multi-dose research use.
- 03Normal saline (0.9% NaCl). Isotonic, compatible with human physiology. Used for some clinical injectable peptides (e.g., degarelix). Provides a slightly different ionic environment than BAC water that may be preferred for certain sequences or injection routes. Bacteriostatic saline (with benzyl alcohol) exists and extends multi-use stability.
- 04Acetic acid (0.6% or dilute aqueous). A specialised diluent for peptides that precipitate at neutral pH. The chemistry is explained below. Not for routine use. Injecting highly acidic solution is uncomfortable and can cause tissue damage at high concentrations. Only appropriate for specific sequences known to require it.
Why some peptides require acetic acid.
Every peptide has an isoelectric point (pI): the pH at which its net electrical charge is zero. At or near the pI, the electrostatic repulsion between molecules is minimised and they aggregate (clump together), precipitating out of solution or forming gels. Moving the pH away from the pI, in either direction, adds net charge and increases intermolecular repulsion, keeping molecules separated and soluble.
Peptides that are basic in character (net positive charge, rich in arginine, lysine, or histidine residues) aggregate at neutral pH and dissolve best in mildly acidic conditions. Acetic acid at 0.6% (pH approximately 3) protonates the basic side chains, creating strong positive charge and electrostatic repulsion. This prevents aggregation and allows the peptide to dissolve.
- 01IGF-1 LR3: Rich in basic residues, high aggregation propensity at neutral pH. Dissolve first in small volume of 0.6% acetic acid, then dilute with BAC water.
- 02GHRP-2 and GHRP-6: Growth hormone-releasing peptides with pH-dependent solubility. Both are more reliably soluble in mild acid. Commonly reconstituted with acetic acid, then diluted.
- 03Hexarelin: Same GHRP class; same acid requirement.
- 04CJC-1295 without DAC (Mod GRF 1-29): The version without the Drug Affinity Complex benefits from acetic acid reconstitution. CJC-1295 with DAC dissolves well in BAC water.
- 05GHK-Cu (copper peptide): The copper-peptide coordination complex is unstable above pH 7.5. Stable at pH 5–6.5; best dissolved in mildly acidic diluent (acetic acid or citrate buffer). The copper ion participates in its own redox chemistry and is more vulnerable to oxidation at alkaline pH.
- 06AOD-9604 and GH fragment 176-191: GH fragments aggregate at neutral pH; acetic acid is the preferred primary solvent.
- 07LL-37 (cathelicidin): A highly cationic antimicrobial peptide. Academic protocols (ResearchGate, manufacturer documentation) specify 0.01% acetic acid for research preparation.
Syringes and needles: understanding the measurements.
The syringe type matters because the markings can be confusing. Most research peptide users draw with an insulin syringe (U-100): a 1 mL syringe marked in “units.” On a U-100 syringe, 100 units = 1 mL; 1 unit = 0.01 mL = 10 µL. These units are volume measurements, not biological units of activity. Do not confuse them with international units (IU) of peptide activity or with mcg of peptide. The conversion depends entirely on the concentration of the solution you mixed.
- 01U-100 insulin syringe (1 mL). Standard for research peptide use. 100 units total; each unit = 0.01 mL. Available in 28–31G needle sizes (25–29G for SC). Very common, affordable, available at pharmacies. Confusing “units” labelling requires careful concentration calculation.
- 02Tuberculin (TB) syringe (1 mL). Marked in 0.01 mL increments: mL only, no “units” labelling. Avoids the unit confusion. Less available than insulin syringes; less commonly stocked in pharmacies. Clinically preferred for precision when the unit confusion matters.
- 03Draw needle vs injection needle. Use a larger gauge (18–21G) to draw peptide from the vial (faster, easier), then switch to a smaller gauge (27–29G) for injection. This preserves the sharp tip of the injection needle and reduces tissue damage. Always draw from the vial with the draw needle, then swap before injecting.
- 04Dead space. The needle hub and syringe tip hold 0.05–0.1 mL that doesn't exit the plunger but stays in the needle. Negligible for larger volumes; can represent 5–10% of a 0.1 mL draw. Account for dead space when drawing very small volumes or when measuring precisely.
The concentration math.
The only arithmetic in reconstitution: total peptide (mg) ÷ diluent volume (mL) = concentration (mg/mL). Converting to micrograms: 1 mg = 1,000 mcg. So 5 mg in 2 mL = 2.5 mg/mL = 2,500 mcg/mL. On a U-100 syringe, 10 units = 0.1 mL = 250 mcg at that concentration. The reconstitution calculator handles this from the values you enter. No mental arithmetic is needed, and no dose is suggested.
Step-by-step reconstitution technique.
- 011 · Equilibrate temperature. Allow the sealed peptide vial to reach room temperature (5–10 minutes from refrigerator). This prevents condensation inside the vial when it's opened, which would change the concentration of any solution you add.
- 022 · Prep surfaces. Clean surface. Wash hands. Swab the rubber stopper of both the peptide vial and the diluent vial with an alcohol swab; allow to air-dry for 10–15 seconds. Alcohol works by denaturing bacterial proteins. It requires contact time, and wet alcohol on a stopper doesn't provide full disinfection.
- 033 · Equalize pressure. Before drawing from the diluent vial, draw a volume of air into the syringe equal to the diluent volume you plan to draw. Inject this air into the peptide vial first. This creates positive pressure that balances the negative pressure (vacuum) inside the sealed vial, preventing the plunger from being sucked in when you add water and making injection easier. Skipping this step creates a vacuum that can collapse syringes or cause the diluent to rush in uncontrolled.
- 044 · Draw and add diluent slowly. Draw your calculated diluent volume. Insert the needle into the peptide vial and let the liquid run down the inside glass wall, not directly onto the peptide powder. Direct spray shears peptide structure, causes foaming, and makes the powder harder to dissolve. Slow is better: 30–60 seconds for a full volume.
- 055 · Swirl, never shake. Gently roll or swirl the vial for 30–60 seconds. The powder should dissolve into a clear solution. Shaking creates an air-water interface that causes denaturation (protein structure is disrupted at interfaces) and foaming. Even gentle vortexing can accelerate aggregation for sensitive sequences.
- 066 · Inspect the solution. Should be: clear to very slightly yellow, no visible particles, no persistent cloudiness. Cloudiness that doesn't resolve in 5 minutes = either solubility exceeded, diluent incompatible, or contamination. Foaming that doesn't settle = shaking occurred. Any strong discoloration (brown, orange) = degradation. Discard a vial you can't confirm as clean and clear.
- 077 · Label and store. Write the reconstitution date and the concentration on the vial label. Refrigerate immediately. Protect from light (amber vial or wrapped in foil). Never leave reconstituted peptide at room temperature longer than necessary for preparation.
How peptides degrade: the chemistry.
Peptides in solution are not inert. They undergo chemical reactions that destroy biological activity over time. Understanding which reactions happen fastest, and what conditions accelerate them, is what makes the handling guidance meaningful rather than arbitrary.
- 011. Oxidation (fastest, starts immediately). Methionine is the most oxidation-vulnerable residue: its thioether group reacts with molecular oxygen, hydrogen peroxide, or reactive oxygen species to form methionine sulfoxide (reversible by cells) or methionine sulfone (irreversible). Cysteine's thiol group similarly oxidises, forming disulfide bonds with itself or other cysteines, often changing peptide structure completely. Tryptophan undergoes both chemical and photochemical oxidation (see light sensitivity below). Dissolved oxygen in the reconstituted solution and headspace oxygen in the vial drive this pathway continuously.
- 022. Deamidation (hours to days at physiological pH). Asparagine (Asn) and glutamine (Gln) residues undergo spontaneous deamidation: the amide group is hydrolysed, converting Asn to aspartate or iso-aspartate, and Gln to glutamate. The Asn-Gly sequence is a “hot spot” for rapid deamidation. pH 3–5 minimises deamidation; neutral and alkaline pH dramatically accelerates it. Temperature doubles the rate per 10°C increase. Deamidated peptide is a different molecule and may have reduced or altered activity.
- 033. Peptide bond hydrolysis (days to weeks). Peptide bonds in -X-Asp-Y- sequences are approximately 100× more labile than other peptide bonds. Acid and base conditions both catalyse hydrolysis. The result is chain cleavage: fragments instead of the full peptide.
- 044. Aggregation (variable; accelerated by concentration, heat, agitation, and interfaces). Peptide monomers associate into oligomers and eventually large insoluble aggregates. Aggregates lose biological activity and may trigger immune responses. This pathway is most relevant at high concentrations and when the peptide has been shaken or repeatedly freeze-thawed.
Storage: what the numbers actually mean.
- 01Room temperature (20–25°C): 24–48 hours maximum before significant chemical degradation begins. Never the primary storage condition. Only acceptable during active use preparation.
- 02Refrigerated (2–8°C), bacteriostatic water: 28–60 days, peptide-dependent. The benzyl alcohol preservative inhibits microbial growth; chemical stability is the limiting factor. Stable sequences (BPC-157) may hold 60 days; sensitive sequences (IGF-1 LR3, Trp-containing) degrade faster. Discard at 28–30 days as a conservative standard.
- 03Refrigerated (2–8°C), sterile water: 24 hours maximum. No preservative means microbial contamination risk begins immediately after puncture.
- 04Frozen (-20°C), single-use aliquots: 1–12 months depending on sequence. Requires aliquoting (dividing into single-use volumes) before freezing to avoid freeze-thaw cycles on each use. Each freeze-thaw cycle causes ice crystal formation that physically damages peptide structure.
- 05Frozen (-80°C), single-use aliquots: 12–24+ months. Best for long-term reconstituted storage of sensitive sequences. Requires avoiding frost-free freezers (temperature cycling from auto-defrost causes micro-thaw damage).
- 01Cloudiness or turbidity that doesn't clear: indicates aggregation or contamination.
- 02Visible particulates: flecks or sediment that don't dissolve; same causes as cloudiness.
- 03Discolouration: yellow is often acceptable (especially at low concentrations); brown, orange, or dark is oxidation or degradation. Discard.
- 04Foul or unusual odour: microbial contamination.
- 05Unusual viscosity: thicker or gel-like solutions indicate aggregation, especially in high-concentration preparations.
- 06Past the discard date: even a visually clear solution beyond its useful window has likely undergone significant chemical degradation that is not visible.
Multi-use vial sterility.
Every time a needle punctures a rubber stopper, a micro-wound is created in the rubber. After 10–20 punctures (exact number depends on rubber formulation, needle gauge, and technique), the risk of “coring” increases, where a small fragment of rubber is cored out by the needle tip and falls into the solution. Rubber particles in an injection cause granuloma formation and injection-site reactions. Prevention: use a fresh needle for each draw, insert needles at a slight angle rather than straight through the same worn channels, and discard vials after significant use even if fluid remains.
- 01Category 2 CSP, all sterile components, aseptic preparation: Refrigerated (2–8°C) up to 10 days maximum. This applies to pharmacy-compounded injectable peptides. Most research-grade self-prepared vials don't meet Category 2 cleanroom conditions, so these limits represent the regulated ceiling, not a recommendation for home preparation.
- 02Practical implication: Home preparation cannot replicate pharmaceutical cleanroom conditions. The benzyl alcohol in BAC water provides meaningful microbial inhibition (not sterilisation), which is why USP <797> still recommends strict aseptic technique even with bacteriostatic diluents. Strict sterile technique (new needles, alcohol-swabbed stoppers with drying time, no hands touching critical surfaces) is the realistic mitigation available outside a cleanroom.
Common mistakes that damage or waste peptides.
- 01Shaking the vial. Creates an air-water interface that denatures peptide chains. Causes foaming. Creates aggregates that are harder to inject accurately and may be immunogenic.
- 02Spraying diluent directly onto the powder. Physical impact fragments lyophilised powder before it's dissolved, causing foaming and potentially denaturing surface molecules. Always run liquid down the vial wall.
- 03Wrong diluent for the sequence. Adding neutral BAC water to a peptide that requires acetic acid causes immediate visible precipitation. At that point the peptide has aggregated and may not fully re-dissolve even with the correct diluent added afterward.
- 04Using sterile water and expecting multi-use stability. Without benzyl alcohol, microbial contamination is a serious risk within hours of puncture. Sterile water is single-use.
- 05Skipping the temperature equilibration step. A cold vial punctured immediately from the freezer can cause condensation inside, diluting the solution or changing it unpredictably.
- 06Storing reconstituted vials at room temperature. Degradation rate approximately doubles per 10°C increase. A vial left on a counter degrades far faster than one refrigerated, potentially reducing it to significantly below label potency within days.
- 07Freeze-thaw cycling. Each cycle creates ice crystals that physically damage the peptide. Aliquot before freezing; thaw once per aliquot; never refreeze a thawed vial.
- 08Using a vial past its reasonable shelf life. A vial that's clear and shows no visual signs of degradation can still have undergone significant deamidation, oxidation, or fragmentation at the molecular level. Chemical degradation is mostly invisible.
FAQ.
What water should I use to reconstitute peptides?
Bacteriostatic water (sterile water with 0.9% benzyl alcohol) is the standard choice for most research peptides because the benzyl alcohol preservative allows a multi-use vial to be drawn from repeatedly over 28–60 days refrigerated. Sterile water has no preservative and is single-use only (within 24 hours). Some peptides require acetic acid as the primary diluent due to pH-dependent aggregation. See the guide section on acetic acid.
Why can't I just shake the vial?
Shaking creates an air-water interface that denatures peptide chains, unfolding their structure, which changes or eliminates biological activity. It also creates foam (bubbles in the solution) that makes accurate measurement impossible and produces aggregates that may trigger immune reactions. Swirling or rolling dissolves the powder without creating this interface.
How much water should I add?
The volume you add determines the concentration: more water means a more dilute solution. There's no correct single answer; it depends on what volume you want to inject and what concentration is practical for your syringe. The reconstitution calculator computes the resulting concentration for any vial size and diluent volume you enter. This guide does not suggest amounts to use.
How long does a reconstituted vial last?
With bacteriostatic water, refrigerated: approximately 28–60 days for stable sequences; shorter for light-sensitive or oxidation-prone peptides. With sterile water: 24 hours maximum. Frozen in single-use aliquots: 1–12+ months depending on the sequence. Discard if the solution is cloudy, discoloured, or past the 28-day mark as a conservative standard.
My peptide solution is cloudy. Should I use it?
Persistent cloudiness after reconstitution (not settling within 5–10 minutes) indicates the peptide has aggregated, caused by exceeding the solubility limit, wrong diluent pH, or degradation. Cloudiness is not cosmetic; it means the solution contains aggregates, not dissolved peptide. Discard and start with a fresh vial and correct technique.
Why does my vial have a yellowish tint?
Light yellow is common and generally normal for many peptide sequences, especially at low concentrations or with benzyl alcohol in the diluent. Brown, orange, or dark yellow is not normal and indicates oxidation or degradation. Discard those vials.
What is a Certificate of Analysis and does it mean the vial is safe?
A CoA reports chemistry: HPLC purity percentage and mass spectrometry identity confirmation. It does not test for sterility, endotoxins (fever-inducing bacterial fragments), or degradation after reconstitution. A 99% pure result means the chemistry passed; it says nothing about whether the vial is microbiologically safe to inject.
Can I mix two peptides in one vial?
Blending reconstituted peptides is done but requires that both peptides are compatible in pH, osmolality, and diluent. Mixing an acid-reconstituted peptide with a BAC-water peptide can cause precipitation at the interface. If blending, mix immediately before use rather than storing blended vials long-term. The blend calculator handles the concentration math for common multi-peptide stacks.
Can I freeze a reconstituted vial and thaw it later?
If you aliquot first into single-use volumes, yes: frozen aliquots at -20°C are stable for 1–12 months depending on the sequence. Each freeze-thaw cycle damages the peptide via ice crystal formation, so aliquot into single-use portions before freezing and thaw each one only once. Don't freeze and repeatedly thaw the same vial.
What is the difference between U-100 syringe 'units' and mcg of peptide?
A U-100 insulin syringe's 'unit' markings are volume measurements: 1 unit = 0.01 mL. The unit marking has nothing to do with mcg of peptide, IU of any compound, or any biological measure. To convert: concentration (mcg/mL) × volume in mL = mcg drawn. The reconstitution calculator does this conversion automatically from your vial size and diluent volume.
Sources.
- [1]Bacteriostatic water for injection USP: FDA / DailyMed labeling · FDA / DailyMed
- [2]Zapadka KL et al.: Factors affecting the physical stability (aggregation) of peptide therapeutics · Interface Focus, 2017 (PMC5665799)
- [3]Nugrahadi PP et al.: Designing formulation strategies for enhanced stability of therapeutic peptides in aqueous solutions · Pharmaceutics, 2023 (PMC10056213)
- [4]Shi M & McHugh KJ: Strategies for overcoming protein and peptide instability in biodegradable drug delivery systems · Adv Drug Deliv Rev, 2023 (PMC10526705)
- [5]Peptide solubility and aggregation behaviour: isoelectric point and pH effects · PMC8905580
- [6]Bachem: Handling and storage guidelines for peptides · Bachem technical documentation
- [7]USP General Chapter <797>: Pharmaceutical Compounding: Sterile Preparations (2023 revision) · United States Pharmacopeia
- [8]Light-sensitive injectable drugs: photodegradation mechanisms · PMC3940680
- [9]Peptide photodegradation: tryptophan, tyrosine, disulfide bonds · PMC10376966
- [10]Semaglutide reconstitution and stability for lyophilised preparations · PubMed / NCBI
Cite this page
PepCue. “How to reconstitute peptides.” PepCue, reviewed June 1, 2026. https://www.pepcue.app/guides/reconstitution.
Track your protocol in PepCue.
Log doses, run the calculators, follow the evidence, and keep peptides, GLP-1s, TRT and labs in one private timeline.